These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS. HANSEN HJ; VANDEVOORDE JP; BENNETT KJ; GILES WG; NADLER SB J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063 [No Abstract] [Full Text] [Related]
45. Effect of azaserine on the biosynthesis of diphosphopyridine nucleotide in mouse. NARROD SA; BONAVITA V; EHRENFELD ER; KAPLAN NO J Biol Chem; 1961 Mar; 236():931-5. PubMed ID: 13727808 [No Abstract] [Full Text] [Related]
46. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine. SARTORELLI AC; LEPAGE GA Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368 [No Abstract] [Full Text] [Related]
47. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS. BOOTH BA; SARTORELLI AC Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870 [No Abstract] [Full Text] [Related]
48. Variation in resistance patterns in different neoplasms. POTTER M Ann N Y Acad Sci; 1958 Dec; 76(3):630-42. PubMed ID: 13627890 [No Abstract] [Full Text] [Related]
49. BIOCHEMICAL AND CARCINOSTATIC EFFECTS OF 2'-DEOXYTHIOGUANOSINE. LEPAGE GA; JUNGA IG; BOWMAN B Cancer Res; 1964 Jun; 24():835-40. PubMed ID: 14190549 [No Abstract] [Full Text] [Related]
50. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity. Catane R; Von Hoff DD; Glaubiger DL; Muggia FM Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801 [TBL] [Abstract][Full Text] [Related]
51. ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE. PATERSON AR Acta Unio Int Contra Cancrum; 1964; 20():1033-6. PubMed ID: 14274687 [No Abstract] [Full Text] [Related]
52. Intestinal transport of azaserine and DON. SPENCER RP; BOW TM; MARKULIS MA Biochem Pharmacol; 1963 Jun; 12():599. PubMed ID: 13990036 [No Abstract] [Full Text] [Related]
53. Observations on the action of azaserine in mammalian tissues. HENDERSON JF; LEPAGE GA; MCIVER FA Cancer Res; 1957 Jul; 17(6):609-12. PubMed ID: 13446847 [No Abstract] [Full Text] [Related]
54. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine. MOORE EC; LEPAGE GA Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988 [No Abstract] [Full Text] [Related]
55. THE HUMAN TUMOR-EGG HOST SYSTEM. III. TUMOR-INHIBITORY PROPERTIES OF TENUAZONIE ACID. GITTERMAN CO; DULANEY EL; KACZKA EA; CAMPBELL GW; HENDLIN D; WOODRUFF HB Cancer Res; 1964 Apr; 24():440-3. PubMed ID: 14147817 [No Abstract] [Full Text] [Related]
56. EXPERIMENTAL SMALL-ARTERY GRAFTS IN DOGS TREATED WITH IMMUNOSUPPRESSIVE DRUGS. VICKERY CM; MCCOMBS HL; WARREN R N Engl J Med; 1965 Feb; 272():325-31. PubMed ID: 14239113 [No Abstract] [Full Text] [Related]
57. Treatment of ascites tumors with 4-aminopyrazolo (3,4-d)pyrimidine alone and in combination with azaserine, thioguanine, and 6-mercaptopurine. HENDERSON JF; JUNGA IG Cancer Res; 1961 Apr; 21(3)Pt 2():7-13. PubMed ID: 13713262 [No Abstract] [Full Text] [Related]
59. Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan. TOMISEK AJ; REID MR; SKIPPER HE Cancer Res; 1959 Jun; 19(5):489-93. PubMed ID: 13663035 [No Abstract] [Full Text] [Related]